Medicine News and Research

RSS

Study estimates the cost-effectiveness of therapeutic alternatives

Giving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce overall costs and improve the value of care while preserving quality of life, according to a study led by UNC Lineberger Comprehensive Cancer Center and UNC Gillings School of Global Public Health researchers.

14 Sep 2022

SARS-CoV-2 viral infection is associated with an increased risk of Alzheimer’s disease

Older people who were infected with COVID-19 show a substantially higher risk - as much as 50% to 80% higher than a control group - of developing Alzheimer's disease within a year, according to a study of more than 6 million patients 65 and older.

14 Sep 2022

New report shines light on the impact of COVID-19 on general practice in Australia

A new report reveals some of the effects of the COVID-19 pandemic on general practice in Australia. The data used is poised to shine a light on how COVID-19 affects long-term health.

14 Sep 2022

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

The multitargeted tyrosine kinase inhibitor (MKI), lenvatinib, is widely used to treat advanced and metastatic thyroid cancer. However, the molecular mechanisms by which thyroid cancer cells become resistant to lenvatinib remain poorly understood. In this study, we demonstrated, for the first time, that activation of the epidermal growth factor receptor (EGFR)-mediated signaling pathway is involved in lenvatinib resistance in thyroid cancer cells.

14 Sep 2022

COVID-19 risk substantially reduced in seniors who receive 4th mRNA booster

In a recent study published in the Annals of Internal Medicine, researchers in Singapore estimated the effectiveness of the second booster (fourth dose) vaccination with messenger ribonucleic acid (mRNA) vaccines against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections with the SARS-CoV-2 Omicron variant and associated hospitalizations with among individuals aged ≥80 years.

14 Sep 2022

Every step counts to lower cancer and cardiovascular disease risk

In a recent study published in JAMA Internal Medicine, researchers in Australia, Denmark, and the United States pursued evidence of an association between daily walking and its intensity with the risk of cancer and cardiovascular diseases (CVDs) in a cohort of 78,500 individuals aged 40 to 79 years in the United Kingdom (UK).

13 Sep 2022

Study finds spike in the "Years of Life Lost" among adolescents during COVID-19 pandemic

The first year of the COVID-19 pandemic saw a 113% increase in the "Years of Life Lost" among adolescents and young people in the United States due to unintentional drug overdose, according to researchers at The Ohio State University Wexner Medical Center and College of Medicine.

13 Sep 2022

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma cells in early-stage lung cancers, highlighting previously unappreciated roles these immune cells play in tumor development and treatment outcomes.

13 Sep 2022

New drug marks cancer cells for destruction by the immune system

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks.

13 Sep 2022

Researchers use data from wearables to predict outcomes of depression treatment

Over the past several years, managing one's mental health has become more of a priority with an increased emphasis on self-care. Depression alone affects more than 300 million people worldwide annually.

13 Sep 2022

COVID found to be the leading cause of death for people with intellectual and developmental disabilities

Authors of a new peer-reviewed paper have discovered that COVID was the leading cause of death for people with intellectual and developmental disabilities (IDD) in 2020.

13 Sep 2022

UC San Diego selected to lead components of the NIH Common Fund's Bridge2AI program

Researchers at University of California San Diego School of Medicine have been selected to lead components of the National Institutes of Health (NIH) Common Fund's Bridge to Artificial Intelligence (Bridge2AI) program.

13 Sep 2022

Review highlights the role of retinol-binding protein-4 in non-alcoholic fatty liver disease

It is a known fact that consuming a large amount of alcohol, even for a few days, triggers fat accumulation in the liver and ultimately leads to alcohol-related liver diseases.

13 Sep 2022

Experimental drug prolongs survival, improves muscle function in mice severe Duchenne muscular dystrophy

Researchers at Johns Hopkins Medicine report that an experimental drug first developed to treat kidney disease prolongs survival and improves muscle function in mice genetically engineered to develop a severe form of Duchenne muscular dystrophy (DMD).

13 Sep 2022

Medicine News and Research

Study estimates the cost-effectiveness of therapeutic alternatives

SARS-CoV-2 viral infection is associated with an increased risk of Alzheimer’s disease

New report shines light on the impact of COVID-19 on general practice in Australia

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

COVID-19 risk substantially reduced in seniors who receive 4th mRNA booster

Every step counts to lower cancer and cardiovascular disease risk

Study finds spike in the "Years of Life Lost" among adolescents during COVID-19 pandemic

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

New drug marks cancer cells for destruction by the immune system

Researchers use data from wearables to predict outcomes of depression treatment

COVID found to be the leading cause of death for people with intellectual and developmental disabilities

UC San Diego selected to lead components of the NIH Common Fund's Bridge2AI program

Review highlights the role of retinol-binding protein-4 in non-alcoholic fatty liver disease

Experimental drug prolongs survival, improves muscle function in mice severe Duchenne muscular dystrophy

In vitro skeletal muscle models could lead to personalized medicine for type 2 diabetes

NIH's Bridge2AI program aims to expand use of AI by biomedical and behavioral research communities

AI system can quickly and automatically evaluate chest X-rays for TB

Deep learning tool highly effective at detecting pancreatic cancer on CT

Discoveries about embryonic blood stem cell creation may solve donor blood stem cell shortages

Vitamin D3 or omega-3 fatty acid supplements do not prevent frailty in older adults

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News